Related Experiment Videos
Control of cell cycle progression by c-Jun is p53 dependent
1Research Institute of Molecular Pathology (IMP), A-1030 Vienna, Austria.
Genes & Development
|March 11, 1999
Summary
The c-Jun protein is crucial for cell proliferation by negatively regulating the p53 tumor suppressor gene. Its absence causes cell cycle defects, highlighting c-Jun
Area of Science:
- Molecular Biology
- Cell Biology
- Oncogenesis
Background:
- The c-Jun proto-oncogene is a transcription factor implicated in cell proliferation.
- AP-1 is a transcription factor complex involving c-Jun, regulating immediate-early gene expression.
- Cell cycle progression, particularly the G1 to S phase transition, is tightly regulated by various factors.
Purpose of the Study:
- To investigate the role of c-Jun in fibroblast proliferation and cell cycle regulation.
- To elucidate the molecular mechanisms by which c-Jun influences cell cycle progression.
- To determine the relationship between c-Jun, p53, and cell proliferation.
Main Methods:
- Generation and analysis of fibroblasts derived from c-jun-/- mouse fetuses.
- Assessment of cell proliferation, cell cycle progression (G1-to-S), and immortalization.
- Analysis of cyclin D1, cyclin E-dependent kinases (CDKs), E2F, p53, and p21 expression.
- Investigation of c-Jun's direct binding to the p53 promoter.
- Deletion of p53 to assess its role in c-Jun deficient cells.
Main Results:
- Fibroblasts lacking c-Jun (c-jun-/-) exhibit severe proliferation defects and delayed immortalization.
- c-jun-/- cells show poor activation of G1 CDKs and E2F, leading to inefficient G1-to-S progression.
- Absence of c-Jun elevates p53 and p21 expression; c-Jun overexpression represses them.
- c-Jun directly binds to the p53 promoter, negatively regulating its transcription.
- Deletion of p53 rescues all proliferation and cell cycle defects in c-jun-/- fibroblasts.
Conclusions:
- c-Jun's essential role in fibroblast proliferation is through negative regulation of p53 expression.
- c-Jun acts as a critical link between mitogenic signaling and cell cycle control.
- Targeting c-Jun or its downstream pathways may offer therapeutic strategies for proliferation-related disorders.